OCX News and Press, Oncocyte Corporation From 08/28/23

First digital-droplet PCR assay to receive coverage Expect initial revenue generation in Q1 2024 IRVINE, CA / ACCESSWIRE / August 28, 2023 / Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced that Palmetto GBA, the Medicare Administrative Contractor ...

2023-08-10 12:06:05 ET OncoCyte Corporation (OCX) Q2 2023 Earnings Conference Call August 10, 2023, 8:00 AM ET Company Participants Stephanie Prince - PCG Advisory, IR Josh Riggs - President and CEO Conference Call Participants Mike Matson - Needham &...

2023-08-10 07:05:33 ET OncoCyte press release ( NASDAQ: OCX ): Q2 GAAP EPS of -$1.03 beats by $0.21 . Revenue of $0.46M (+91.7% Y/Y) beats by $0.11M . Cash, cash equivalents, and marketable securities totaled $17.9 million at June 30, 2023, with average cash bu...

Conference Call on Thursday, August 10, 2023, at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA / ACCESSWIRE / August 10, 2023 / Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today reported financial results for the second quarter of 2023, ended June 30, 2023. Second Quarte...

2023-08-09 14:09:04 ET OncoCyte ( NASDAQ: OCX ) is scheduled to announce Q2 earnings results on Thursday, August 10th, before market open. The consensus EPS Estimate is -$0.59 (-742.9% Y/Y) and the consensus Revenue Estimate is $0.35M (-83.3% Y/Y).Over the last 3 months, EPS...

IRVINE, CA / ACCESSWIRE / August 9, 2023 / Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced that it has received written notice from the Listing Qualifications Staff of the Nasdaq Stock Market ("Nasdaq") stating that the Company has regained compliance with the...

CEO Josh Riggs will be meeting with registered investors on Tuesday, August 15, 2023 IRVINE, CA / ACCESSWIRE / August 8, 2023 / Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, announced today that it will participate in the 8th Annual Needham Virtual MedTech & Diagnos...

Conference Call and Webcast on Thursday, August 10, 2023, at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA / ACCESSWIRE / August 3, 2023 / Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, announced today that it will release its second quarter 2023 financial results on Thursday, ...

- Blood-based test differentiates between ABMR and IgAN, enabling faster and more effective treatment - Improved utility over standard of care tests - Paper published in peer-reviewed journal IRVINE, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a pre...

2023-07-24 14:37:06 ET Oncocyte will implement a 1-for-20 reverse stock split reverse at 5p Pacific Time on Monday. Shares, which are down 9% Monday , will begin trading on a post-split basis on July 25. The reverse split will cut the number of outstanding shares to 8...